跳至主要内容
临床试验/NCT05274503
NCT05274503已完成不适用

Serum Interleukine 6 as a Predictor of Outcome in Mechanically Ventilated Patients With Covid 19

Sohag University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2021年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
detection of acute respiratory distress syndrome

研究概览

简要总结

Serum IL-6 levels will be determined by enzyme-linked immunosorbent assay according to the manufacturer's instructions and the normal range is <10 pg/mL , Patients' medical records will be carefully reviewed and analyzed. Patient data regarding demographics, comorbidities, signs and symptoms, laboratory results and complications will be collected. The occurrence of complications will be confirmed according to the following criteria: acute respiratory distress syndrome (ARDS) defined according to the Berlin definition

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • •Age: more than 20 years.
  • Gender: both males and females will be included.
  • Mechanically Ventilated patients.
  • COVID 19 confirmed diagnosis

排除标准

  • •Immunocompromised patients.
  • Oxygen saturation more than 95% without ventilation.
  • Malignancy.
  • Patients refuse to be enrolled in the study.

结局指标

主要结局

detection of acute respiratory distress syndrome

时间窗: 2 weeks

hypoxia, incresed plateau pressure

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Islam Mokhtar Ahmed

lecturer of anesthesia and intensive care

Sohag University

研究点 (1)

Loading locations...

相似试验